liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Diagnostic accuracy for colorectal cancer of a quantitative faecal immunochemical test in symptomatic primary care patients: a study protocol
Department of Medical Sciences, Örebro University; Skebäck Primary Care Centre, Region Örebro län, Örebro.
Department of Public Health and Clinical Medicine, Unit of Research, Education and Development Östersund, Umeå University, Umeå.
Department of Public Health and Clinical Medicine, Unit of Research, Education and Development Östersund, Umeå University, Umeå.
Linköping University, Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Diagnostics, Department of Clinical Chemistry.ORCID iD: 0000-0003-0756-7723
Show others and affiliations
2022 (English)In: Diagnostic and Prognostic Research, E-ISSN 2397-7523, Vol. 6, no 1, article id 16Article in journal (Refereed) Published
Abstract [en]

Background: There is increasing evidence supporting the use of faecal immunochemical tests (FIT) in patients reporting symptoms associated with colorectal cancer (CRC), but most studies until now have focused on selected subjects already referred for investigation. We therefore set out to determine the accuracy and predictive values of FIT in a primary care population.

Method: A prospective, multicentre, single-gated comparative diagnostic study on quantitative FIT in patients aged 40 years and above presenting in primary care with symptoms associated with CRC will be conducted. Patients representing the whole spectrum of severity of such symptoms met with in primary care will be eligible and identified by GPs. Participants will answer a short form on symptoms during the last month. They will provide two faecal samples from two separate days. Analyses will be performed within 5 days (QuikRead go®, Aidian Oy). The analytical working range is 10-200 μg Hb/g faeces. Reference test will be linked to the Swedish Colorectal Cancer Registry up to 2 years after inclusion. Accuracy, area under ROC curves, and predictive values will be calculated for one FIT compared to the highest value of two FIT and at cutoff < 10, 10-14.9, 15-19.9 and ≥ 20 μg Hb/g faeces. Subgroup analyses will be conducted for patients with anaemia and those reporting rectal bleeding. A model-based cost-effectiveness analysis based on the clinical accuracy study will be performed. Based on previous literature, we hypothesized that the sensitivity of the highest value of two FIT at cutoff 10 μg Hb/g faeces will be 95% (95% CI + / - 15%). The prevalence of CRC in the study population was estimated to be 2%, and the rate of non-responders to be 1/6. In all, 3000 patients will be invited at 30 primary care centres.

Discussion: This study will generate important clinical real-life structured data on accuracy and predictive values of FIT in the most critical population for work-up of CRC, i.e. patients presenting with at times ambiguous symptoms in primary care. It will help establish the role of FIT in this large group.

Place, publisher, year, edition, pages
Springer, 2022. Vol. 6, no 1, article id 16
Keywords [en]
Colorectal cancer; Diagnostic accuracy study; Primary care; Quantitative faecal immunochemical test; Sensitivity
National Category
Cancer and Oncology General Practice
Identifiers
URN: urn:nbn:se:liu:diva-191943DOI: 10.1186/s41512-022-00129-7ISI: 001210931700001OAI: oai:DiVA.org:liu-191943DiVA, id: diva2:1739638
Funder
Swedish Cancer SocietyÖrebro UniversityNyckelfondenAvailable from: 2023-02-27 Created: 2023-02-27 Last updated: 2025-08-28Bibliographically approved

Open Access in DiVA

fulltext(820 kB)101 downloads
File information
File name FULLTEXT01.pdfFile size 820 kBChecksum SHA-512
4035c33844683d687d1324711afc8b6eb199d3a97f6e7945cbfe8ed4dd39e61c4bd2922ed4b8bf9125febdb2f335d2fc992e618ff6cf6f47dbd3796b58353de4
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records

Theodorsson, Elvar

Search in DiVA

By author/editor
Theodorsson, Elvar
By organisation
Division of Clinical Chemistry and PharmacologyFaculty of Medicine and Health SciencesDepartment of Clinical Chemistry
In the same journal
Diagnostic and Prognostic Research
Cancer and OncologyGeneral Practice

Search outside of DiVA

GoogleGoogle Scholar
Total: 102 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 115 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf